Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome.
Vivek Chand GoodooryCho Ee NgChristopher J BlackAlexander Charles FordPublished in: Alimentary pharmacology & therapeutics (2022)
Patients are willing to accept significant risks in return for cure of their IBS symptoms.
Keyphrases
- irritable bowel syndrome
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- healthcare
- peritoneal dialysis
- prognostic factors
- emergency department
- sleep quality
- physical activity
- depressive symptoms
- risk assessment
- patient reported outcomes
- human health
- adverse drug
- electronic health record